KNTE

Kinnate Biopharma Inc. Common Stock
KNTE

Overview Fund Activity
Delisted

KNTE was delisted on the 2nd of April, 2024.

Back to rankings

55 hedge funds and large institutions have $1.43B invested in Kinnate Biopharma Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 55 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+55
Holders Change %
–
% of All Funds
0.98%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
%
% of All Funds
0.11%
New
55
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FCMI
1
Foresite Capital Management IV
California
$385M
2
O
2
OrbiMed
New York
$153M
3
RCM
3
RA Capital Management
Massachusetts
$143M
4
VVA
4
Vida Ventures Advisors
Massachusetts
$109M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$94.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
PHK
51
Point72 Hong Kong
Hong Kong
$217K +$217K +5,463 New
Rockefeller Capital Management
52
Rockefeller Capital Management
New York
$129K +$129K +3,260 New
IC
53
Ikarian Capital
Texas
$79K +$79K +2,000 New
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$20K +$20K +500 New
PFO
55
Pathstone Family Office
New Jersey
$8K +$8K +198 New
1 2
3